Download | < Back |
13 Aug 2015 | |
Lincoln Pharmaceuticals Ltd, vide its letter dated August 12, 2015, has informed BSE about a Company Note titled "LPL - R&D has developed an Extended Release Oral Suspension (Cough Syrup) brand name is NAMCOLD- DX(First Time In India)". | |
View all announcements for LINCOLN PHARMACEUTICALS LTD. | Source: BSE India |